Fred Derheimer

Company: Boundless Bio

Job title: Senior Director, Drug Discovery Biology

Seminars:

Coming Full Circle, Identification, & Therapeutic Targeting of Extrachromosomal DNA 11:45 am

Discovery and utilization of CHK1 and RNR inhibitors for the treatment of oncogene amplified cancers Establishment of a diagnostic for identification of patients with amp/ecDNA containing tumors Addressing the clinical unmet need presented by oncogene amplified tumors utilizing ecDTx therapiesRead more

day: Pre-Conference Biomarker Focus Day AM